Teva Continues Restructuring With 46 Cuts in Pennsylvania Post author:Sam Post published:February 7, 2018 Post category:BioPharma The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace You Might Also Like This $4 Billion Asian Drugmaker With U.S. Ops Just Went on the Market September 25, 2017 FDA's Shorten Review Time is a Bad Sign for Puma Biotech's Controversial Cancer Drug April 18, 2017 Exactech Goes Private in $625M Deal With TPG Capital October 22, 2017